Efficacy and safety of neoadjuvant immunotherapy protocols and cycles for non-small cell lung cancer: a systematic review and meta-analysis
Article in Frontiers in Oncology (January 2024)
The most recent citing publications are shown below. View all 12 publications that cite this research output on Dimensions.
Efficacy, safety, and survival of neoadjuvant immunochemotherapy in operable non-small cell lung cancer: a systematic review and meta-analysis
Article in Frontiers in Immunology (December 2023)
Does major pathological response after neoadjuvant Immunotherapy in resectable nonsmall-cell lung cancers predict prognosis? A systematic review and meta-analysis
Article in International Journal of Surgery (May 2023)